UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 75 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 5.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $41,000 | -51.2% | 104,591 | +40.1% | 0.00% | – |
Q1 2022 | $84,000 | +223.1% | 74,650 | +322.9% | 0.00% | – |
Q4 2021 | $26,000 | -93.3% | 17,650 | -72.7% | 0.00% | – |
Q1 2021 | $387,000 | +14.2% | 64,561 | -0.3% | 0.00% | – |
Q4 2020 | $339,000 | +52.7% | 64,723 | +1.0% | 0.00% | – |
Q3 2020 | $222,000 | – | 64,075 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund V Management, LLC | 491,751 | $275,000 | 2.22% |
GSA CAPITAL PARTNERS LLP | 639,937 | $361,000 | 0.05% |
PURA VIDA INVESTMENTS, LLC | 359,089 | $202,000 | 0.01% |
Caption Management, LLC | 725,000 | $409,000 | 0.01% |
Forefront Analytics, LLC | 20,377 | $11,000 | 0.01% |
Johnson Midwest Financial, LLC | 6,100 | $3,000 | 0.00% |
Virtu Financial LLC | 62,640 | $35,000 | 0.00% |
Caption Management, LLC | 225,000 | $127,000 | 0.00% |
SeaCrest Wealth Management, LLC | 25,000 | $14,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 191,450 | $108,000 | 0.00% |